Antagonist activity at PGD2 receptor in human platelets assessed as inhibition of PGD2-mediated cAMP accumulation preincubated for 5 mins followed by ...

Basic Information

ID: ALA3881216

Type: Functional

Description: Antagonist activity at PGD2 receptor in human platelets assessed as inhibition of PGD2-mediated cAMP accumulation preincubated for 5 mins followed by PGD2 addition measured after 2 mins by HTRF assay

Format: BAO_0000019

Organism: Homo sapiens

Target:  Prostanoid DP receptor(ALA4427)

Document:  ALA3880428

Antagonist activity at PGD2 receptor in human platelets assessed as inhibition of PGD2-mediated cAMP accumulation preincubated for 5 mins followed by PGD2 addition measured after 2 mins by HTRF assay: 38

Activity Charts

Compound Summary

Parent Molecular WeightALogPPolar Surface Area
501.563.103.10
532.643.283.28
500.582.632.63
478.532.392.39
477.583.733.73
468.963.103.10
476.552.652.65
543.603.293.29
545.572.082.08
502.552.502.50
514.402.612.61
465.543.863.86
477.541.551.55
482.993.493.49
459.522.322.32
510.614.124.12
452.963.273.27
516.644.184.18
445.543.803.80
502.552.502.50
568.652.772.77
475.563.813.81
486.953.243.24
561.642.552.55
513.413.213.21
470.492.732.73
544.592.692.69
534.642.982.98
482.993.493.49
573.693.443.44
458.542.422.42
507.572.632.63
479.512.362.36
500.573.713.71
518.622.972.97
593.663.583.58
557.632.432.43
465.964.074.07
557.632.972.97
544.592.692.69
467.974.164.16
526.614.244.24
560.653.163.16
510.614.124.12
558.613.003.00
583.673.303.30
502.513.473.47
448.542.762.76
464.973.743.74
517.633.573.57
482.993.493.49
530.603.623.62
468.963.103.10
517.602.342.34
482.004.384.38
531.632.592.59
500.573.713.71
471.482.122.12
452.502.592.59
469.952.502.50
447.553.723.72
535.623.413.41
500.573.713.71
502.592.452.45
553.643.703.70
516.582.812.81
519.622.592.59
435.501.841.84
540.644.034.03
491.571.811.81
554.633.103.10
513.413.213.21
554.633.103.10
485.033.813.81
515.593.413.41
448.542.762.76
468.963.103.10
553.643.703.70
501.563.103.10